Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa

Saved in:

Bibliographic Details
Published in:	Amyloid Vol. 23; no. 4; pp. 260 - 261
Main Authors:	Ostrovršnik, Jaka, Hočevar, Alojzija, Lestan, Boris, Sodin Šemrl, Snežna, Lakota, Katja, Tomšič, Matija
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis 01-12-2016
Subjects:	AA amyloidosis Amyloidosis - complications Amyloidosis - drug therapy Amyloidosis - metabolism Amyloidosis - pathology Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Anticholesteremic Agents - therapeutic use Heart Function Tests Humans Hyperlipidemias - chemically induced Hyperlipidemias - drug therapy Hyperlipidemias - pathology Polyarteritis nodosa Polyarteritis Nodosa - complications Polyarteritis Nodosa - drug therapy Polyarteritis Nodosa - metabolism Polyarteritis Nodosa - pathology Rosuvastatin Calcium - therapeutic use serum amyloid A Serum Amyloid A Protein - antagonists & inhibitors Serum Amyloid A Protein - metabolism Time Factors tocilizumab Treatment Outcome vasculitis tocilizumab AA amyloidosis Polyarteritis nodosa serum amyloid A vasculitis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	1350-6129 1744-2818
DOI:	10.1080/13506129.2016.1232648